Xencor | XNCR - Валовая прибыль





Валовая прибыль Изменить Дата
AbbVie USD 12.54B 474M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Amgen USD 6.89B 415M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Biogen USD 1.82B 169.5M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Cytokinetics USD 19.2M 1.44M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
J&J USD 17.24B 642M 2026-03
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
MacroGenics USD 11.24M 19.87M 2026-03
Merck USD 10.85B 2.57B 2025-12
Novartis USD 10.07B 184M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Xencor USD 21M 22.61M 2025-09